Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography

European Journal of Nuclear Medicine

Volumn 24, Issue 6, 1997, Pages 674-677

  Booij, J ^a   Korn, P ^a   Linszen, D H ^a   Van Royen, E A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Constant infusion; D2 receptors; Iodine 123 iodobenzamide; Methylphenidate; Single photon emission tomography

Indexed keywords

BENZAMIDE DERIVATIVE; DOPAMINE; IODINE 123; METHYLPHENIDATE;

ADULT; ANXIETY; ARTICLE; BEHAVIOR; BODY POSTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOUBLE BLIND PROCEDURE; EXCITABILITY; GESTURE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TENSION;

ADULT; BEHAVIOR; BENZAMIDES; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DOUBLE-BLIND METHOD; HUMANS; IODINE RADIOISOTOPES; MALE; METHYLPHENIDATE; PYRROLIDINES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030797219     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050105     Document Type: Article

References (12)

1. Volkov ND, Fowler JS, Galley SJ, et al. PET evaluation of the dopamine system of the human brain. J Nucl Med 1996; 37: 1242-1256.
2. 123M]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease. Eur J Nucl Med 1997; 24: 68-71.
3. Farde L, Nordström AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Positron emission tomography analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Arch Gen Psychiatry 1992; 49: 538-544.
4. 11C]raelopride in the human brain. Synapse 1994; 16: 255-262.
5. Laruelle M, Abi-Dargham A, van Dyck CH, et al. SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med 1995; 36: 1182-1190.
6. Laruelle M, Abi-Dargham A, van Dyck CH, et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 1996; 93: 9235-9240.
7. Gatley SJ, Pan D, Chen R, Chaturvedi G, Ding Y-S. Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci 1996; 58: 231-239.
8. 123I-IBZM. J Lab Comp Radiopharm 1990; 28: 1247-1256.
9. 123I-IBZM SPECT: technical and inter-observer variability. J Nucl Med 1993; 34: 2076-2084.
10. Kay SR, Opler LA, Fiszbeing A. Positive and negative syndrome scale (PANNS) manual. North Tonawanda, N.Y. MultiHealth Systems, 1986.
11. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987; 237: 1219-1223.
12. Wang G-J, Volkow ND, Fowler JS, et al. Methylphenidate decreases regional cerebral blood flow in normal human subjects. Life Sci 1994; 54: 143-146.